Masimo is a global leader in innovative noninvasive monitoring technologies, including medical devices, a wide array of sensors, and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. In 1995, Masimo debuted SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to accurately monitor SpO2 in challenging conditions. SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world each year, touching 3 patients every second. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, such as total hemoglobin (SpHb®). We continue to advance noninvasive monitoring through innovations like Root®, Radius-7®, and Rad-97™, while expanding into new markets with SedLine® brain monitoring, O3® regional oximetry, NomoLine™ capnography, and automation and connectivity solutions such as Patient SafetyNet™.